NDC 51990-201

Sorafenib

Sorafenib

Sorafenib is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Yabao Pharmaceutical Co., Ltd. Beijing. The primary component is Sorafenib.

Product ID51990-201_4b88189b-2e1d-4778-80cb-dd41e57f5908
NDC51990-201
Product TypeHuman Prescription Drug
Proprietary NameSorafenib
Generic NameSorafenib
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-12-31
Marketing CategoryANDA /
Application NumberANDA209050
Labeler NameYabao Pharmaceutical Co., Ltd. Beijing
Substance NameSORAFENIB
Active Ingredient Strength200 mg/1
Pharm ClassesKinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 51990-201-06

60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51990-201-06)
Marketing Start Date2021-12-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Sorafenib" or generic name "Sorafenib"

NDCBrand NameGeneric Name
0480-5425SorafenibSorafenib
24979-715SorafenibSorafenib
43598-458sorafenibsorafenib
51990-201SorafenibSorafenib
50419-488Nexavarsorafenib
0378-1201Sorafenib TosylateSorafenib

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.